IGFL2 Gene

Name IGF-like family member 2
Description IGFL2 belongs to the insulin-like growth factor (IGF; see MIM 147440) family of signaling molecules that play critical roles in cellular energy metabolism and in growth and development, especially prenatal growth (Emtage et al., 2006 [PubMed 16890402]).[supplied by OMIM, Mar 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Multiple studies have implicated the insulin‐growth factor–like family member 2 (IGFL2) and its antisense long noncoding transcript (IGFL2‐AS1) in diverse pathological contexts. In Sézary syndrome, for example, IGFL2 is among a set of novel genes significantly overexpressed in malignant CD4+ T cells compared with controls, suggesting a potential role in disease diagnosis and pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond cutaneous T‐cell lymphoma, IGFL2 has been linked to metabolic dysregulation; genetic polymorphisms in IGFL2 are associated with elevated fasting plasma glucose levels and an increased risk of type 2 diabetes mellitus, highlighting its potential metabolic significance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In proteomic analyses aimed at detecting missing proteins, IGFL2 has also been identified in human placenta, confirming its translational expression and hinting at broader biological roles."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n The antisense transcript IGFL2‐AS1 emerges as a critical regulatory RNA in multiple cancers. In gastric cancer, IGFL2‐AS1 is highly expressed and functions as a competitive endogenous RNA by sponging miR‐802, thereby promoting tumor cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similar oncogenic roles for IGFL2‐AS1 have been observed in basal‐like breast cancer, where it cooperates with transcription factors to upregulate its neighboring IGFL1 and support pro‐survival and proliferative pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In tongue squamous cell carcinoma, IGFL2‐AS1 enhances tumor progression by acting as a molecular sponge for miR‐1224‐5p, which in turn modulates the expression of SATB1 and activates the Wnt/β‐catenin pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, IGFL2‐AS1 has been implicated in broader competing endogenous RNA (ceRNA) networks that influence tumor progression, as demonstrated by its inclusion among several ceRNAs regulating miR‐802 in diverse malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its roles in hematological malignancy, metabolic disorders, and various solid tumors including gastric, breast, and tongue cancers, IGFL2 also appears in the tumor microenvironment. For instance, it is part of a 12‐marker panel associated with cancer‐associated fibroblasts in hepatocellular carcinoma, suggesting it may contribute to the remodeling of the tumor stroma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Similarly, in the context of mitochondrial dysfunction, IGFL2 expression is downregulated in human skin fibroblasts, aligning with a broader suppression of growth factors and cytokines that protect against apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, IGFL2‐AS1 has also been identified as a prognostic biomarker in colon adenocarcinoma, where its high expression correlates with enhanced epithelial‐mesenchymal transition and worse clinical outcomes"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": ", as well as in clear cell renal cell carcinoma, where it forms part of a panel of candidate lncRNAs with diagnostic and prognostic value."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, both IGFL2 and IGFL2‐AS1 are emerging as multifaceted regulators with potential roles in modulating cell proliferation, survival, migration, and metabolic processes. Their dysregulation in various cancers and metabolic disorders underlines their promise as diagnostic biomarkers and as targets for therapeutic intervention.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "N Booken, A Gratchev, J Utikal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.leu.2405044"}], "href": "https://doi.org/10.1038/sj.leu.2405044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18033314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18033314"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Siqi Ge, Youxin Wang, Manshu Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "OMICS (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/omi.2018.0053"}], "href": "https://doi.org/10.1089/omi.2018.0053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30004843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30004843"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhilong Lin, Yuanliang Zhang, Huozhen Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternative Strategy To Explore Missing Proteins with Low Molecular Weight."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteome Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/acs.jproteome.9b00353"}], "href": "https://doi.org/10.1021/acs.jproteome.9b00353"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31592669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31592669"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yu Ma, Yi Liu, Yan-Song Pu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA IGFL2-AS1 functions as a ceRNA in regulating ARPP19 through competitive binding to miR-802 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.23155"}], "href": "https://doi.org/10.1002/mc.23155"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31943339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31943339"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Haixia Wang, Yujie Shi, Chuan-Huizi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2021.04.016"}], "href": "https://doi.org/10.1016/j.canlet.2021.04.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34052325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34052325"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Chongyang Ren, Xiaojiang Tang, Haitao Lan "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PeerJ (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7717/peerj.11377"}], "href": "https://doi.org/10.7717/peerj.11377"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33987034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33987034"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ruimin Zhao, Shiyang Wang, Lu Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IGFL2-AS1 facilitates tongue squamous cell carcinoma progression via Wnt/β-catenin signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oral Dis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/odi.13935"}], "href": "https://doi.org/10.1111/odi.13935"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34085359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34085359"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tong Gao, Mengsha Zou, Tiancheng Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysfunction of miR-802 in tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lab Anal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcla.23989"}], "href": "https://doi.org/10.1002/jcla.23989"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34558723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34558723"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Baojia Zou, Xialei Liu, Yihang Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S176152"}], "href": "https://doi.org/10.2147/CMAR.S176152"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30464627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30464627"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Vladimir N Ivanov, Shanaz A Ghandhi, Hongning Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Radiation response and regulation of apoptosis induced by a combination of TRAIL and CHX in cells lacking mitochondrial DNA: a role for NF-κB-STAT3-directed gene expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2011.03.012"}], "href": "https://doi.org/10.1016/j.yexcr.2011.03.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21440540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21440540"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiaoning Cen, Yunmei Huang, Zhuangnian Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA IGFL2-AS1 Promotes the Proliferation, Migration, and Invasion of Colon Cancer Cells and is Associated with Patient Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S313775"}], "href": "https://doi.org/10.2147/CMAR.S313775"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34377016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34377016"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Kirsten M Tracy, Coralee E Tye, Natalie A Page, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selective expression of long non-coding RNAs in a breast cancer cell progression model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.25997"}], "href": "https://doi.org/10.1002/jcp.25997"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28488769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28488769"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gong Cheng, Di Liu, Huageng Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102407"}], "href": "https://doi.org/10.18632/aging.102407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31727869"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31727869"}]}]}]}
Synonyms UNQ645, VPRI645
Proteins IGFL2_HUMAN
NCBI Gene ID 147920
API
Download Associations
Predicted Functions View IGFL2's ARCHS4 Predicted Functions.
Co-expressed Genes View IGFL2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View IGFL2's ARCHS4 Predicted Functions.

Functional Associations

IGFL2 has 2,168 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 57 datasets.

Click the + buttons to view associations for IGFL2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of IGFL2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of IGFL2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of IGFL2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of IGFL2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of IGFL2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of IGFL2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of IGFL2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of IGFL2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of IGFL2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of IGFL2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of IGFL2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing IGFL2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing IGFL2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with IGFL2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with IGFL2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of IGFL2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with IGFL2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by IGFL2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with IGFL2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with IGFL2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at IGFL2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of IGFL2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of IGFL2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing IGFL2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of IGFL2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of IGFL2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of IGFL2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of IGFL2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of IGFL2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Cellular Component Annotations 2015 cellular components containing IGFL2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GTEx eQTL 2025 SNPs regulating expression of IGFL2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of IGFL2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of IGFL2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of IGFL2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWASdb SNP-Disease Associations diseases associated with IGFL2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with IGFL2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of IGFL2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of IGFL2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of IGFL2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of IGFL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of IGFL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of IGFL2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of IGFL2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain IGFL2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of IGFL2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for IGFL2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of IGFL2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at IGFL2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of IGFL2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of IGFL2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of IGFL2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of IGFL2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of IGFL2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of IGFL2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of IGFL2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with IGFL2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with IGFL2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.